Literature DB >> 15191786

Sustained release veterinary parenteral products.

Natalie J Medlicott1, Niki A Waldron, Todd P Foster.   

Abstract

Controlled release parenteral dosage forms have application in veterinary medicine. Systems that minimize the need for repeated injections while achieving therapeutic effects for extended periods offer benefits that make commercial development of these products desirable. While some products have already found commercial success, others will result from application of new controlled release technologies. This review highlights the formulation and technology challenges in developing some of these controlled release technologies into products. Further, examples of application of controlled release technologies in the veterinary field are discussed.

Mesh:

Substances:

Year:  2004        PMID: 15191786     DOI: 10.1016/j.addr.2004.02.005

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  4 in total

Review 1.  In vitro-in vivo correlation for complex non-oral drug products: Where do we stand?

Authors:  Jie Shen; Diane J Burgess
Journal:  J Control Release       Date:  2015-09-28       Impact factor: 9.776

Review 2.  Critical factors influencing the in vivo performance of long-acting lipophilic solutions--impact on in vitro release method design.

Authors:  Susan Weng Larsen; Claus Larsen
Journal:  AAPS J       Date:  2009-11-06       Impact factor: 4.009

3.  Design and characterisation of a polyethylene oxide matrix with the potential use as a teat insert for prevention/treatment of bovine mastitis.

Authors:  Sushila Bhattarai; Raid G Alany; Craig R Bunt; Hamdy Abdelkader; Michael J Rathbone
Journal:  AAPS J       Date:  2014-10-16       Impact factor: 4.009

4.  A comparative pharmacokinetic study of a novel sustained release danofloxacin formulation and the conventional product in rabbits.

Authors:  Ali Rassouli; Katayoun Kiani; Yalda Hosseinzadeh Ardakani; Hamid Akbari Javar; Sakineh Khanamani Falahatipour
Journal:  Vet Res Forum       Date:  2021-06-15       Impact factor: 1.054

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.